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and Arkadiusz Matwijczuk 7
1

2

3

4

5



Citation: Karcz, D.; Starzak, K.;

6

7

Ciszkowicz, E.; Lecka-Szlachta, K.;
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Abstract: A series of coumarin-thiadiazole hybrids and their corresponding Cu(II) and Zn(II) complexes were synthesized and characterized with the use of spectroscopic techniques. The results
obtained indicate that all the coumarin-thiadiazole hybrids act as bidentate chelators of Cu(II) and
Zn(II) ions. The complexes isolated differ in their ligand:metal ratio depending on the central
metal. In most cases, the Zn(II) complexes are characteristic of a 1:1 ligand:metal ratio, while in the
Cu(II) complexes the ligand:metal ratio is 2:1. All compounds were tested as potential antibacterial
agents against Gram-positive (Staphylococcus aureus, Staphylococcus epidermidis) and Gram-negative
(Escherichia coli, Pseudomonas aeruginosa) bacterial strains demonstrating activities notably lower than
commercially available antibiotics. The more promising results were obtained from the assessment
of antineurodegenerative potency as all compounds showed moderate acetylcholinesterase (AChE)
inhibition activity
Keywords: coumarin; thiadiazole; hybrids; complexes; antimicrobial; antibacterial activity;
acetylcholinesterase inhibitors; neurodegeneration
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The incorporation of two or more potent pharmacophores into a single hybrid molecule
is a growing trend in the design of novel therapeutic agents. Novel hybrid derivatives
can demonstrate biological activities higher than those of the corresponding precursors
together with much lower toxicity and reduced side effects. This recent trend in drug
design becomes particularly visible in the field of coumarin chemistry [1,2], with an increasing number of novel coumarin-derived hybrids reported with a strong emphasis on their
various enzyme inhibitory activities [3–7]. Similar progress is observed in 1,3,4-thiadiazole
chemistry, where various hybrids and conjugates are reported to possess a broad array of
biological activities [8–10]. For instance, a series of resorcynyl-substituted 1,3,4-thiadiazoles
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have been reported as effective antifungal agents [11] and some of these compounds
demonstrated the ability to enhance the anti-Candida activity of the polyene-based drug
amphotericin B [12]. Moreover, some of these 1,3,4-thiadiazole derivatives exhibited notable antitumor activity [13], while other analogs from this group demonstrated significant
antineurodegenerative potency [14,15].
Coumarins and 1,3,4-thiadiazoles are of scientific interest mainly due to their high
affinity to transition metal ions, broad array of biological activities, and often unusual
physiochemical characteristics. Our previous works evidenced a wide variety of coumarinderived ligands and their transition metal complexes as potential antimicrobial and antitumor agents [16–23]. Moreover, we established a fluorescence quenching-based mechanism
of interaction between a number of fluorescent coumarins and the hypochlorite ion [24],
which was then successfully applied for the determination of anti-hypochlorite activity in
a number of plant extracts [25,26]. More recently, a series of 1,3,4-thiadiazole derivatives
acting as effective ligands in the synthesis of transition metal complexes with biologically
important Cu(II) and Zn(II) ions was reported by our group [27,28]. Interestingly, the
concomitant application of these new derivatives with commercial antibiotic Kanamycin
demonstrated a strong synergistic antibacterial effect against Staphylococcus aureus [29].
The design of novel coumarin and 1,3,4-thiadiazole-derived ligands for the synthesis
of biologically active transition metal complexes was a natural driving force for our work
to evolve towards the development of coumarin-thiadiazole hybrids. Therefore, in this
work, we report on the isolation and structural elucidation of novel coumarin-thiadiazole
hybrids in which the coumarin nucleus is linked with the thiadiazole moiety at the C8
carbon (Figure 1). Moreover, a series of transition metal complexes incorporating coumarinthiadiazole ligands and the Cu(II) and Zn(II) ions were isolated and their molecular structures elucidated. The biological activity of the resulting ligands and complexes was determined using assays to determine their antibacterial activity against five various bacterial
strains. In addition, the antineurodegenerative potency of all compounds was assessed by
the determination of their acetylcholinesterase (AChE) inhibition ability. The novelty of
our work is particularly worth emphasizing in the context of the relative
scarcity of reports
Int. J. Mol. Sci. 2021, 22, x FOR PEER REVIEW
3 of 23
dealing with the anti-AChE activity of transition metal complexes.

Figure 1. Synthetic pathway for the synthesis of coumarin-thiadiazole hybrids (2–5) and their corFigure
1. Synthetic pathway for the synthesis of coumarin-thiadiazole hybrids (2–5) and their
responding Cu(II) and Zn(II) complexes 6–13: (A) H2SO4, 25 °C; (B) POCl3, thiosemicarbazide, 75 °C;
◦ C; (B) POCl , thiosemicarbazide,
corresponding
Cu(II)
and Zn(II)
complexes
HEtOH/H
(C) Cu(CH3COO)2xH
2O, EtOH/H
2O, reflux;
(D) Zn(CH6–13:
3COO)2(A)
xH2O,
2O, reflux.
For clarity,
2 SO4 , 25
3
◦
the
aqua
ligands
in
the
complexes
were
omitted
from
the
above
figure.
75 C; (C) Cu(CH3 COO)2 xH2 O, EtOH/H2 O, reflux; (D) Zn(CH3 COO)2 xH2 O, EtOH/H2 O, reflux.
For clarity, the aqua ligands in the complexes were omitted from the above figure.

The evaluation of antibacterial activities in coumarin-thaidiazole hybrids and their
metal complexes was inspired by the rising incidences of resistance of microbes to existing
antibiotics, which necessitates the design of novel therapeutic agents [30,31]. In terms of
the Cu(II) and Zn(II) complexes, the antibacterial study was driven by previously observed effects of an increase in activities of coumarins upon their complexation with various metal salts [16,17,32]. The assessment of anti-AChE potency in hybrids and complexes obtained was inspired by a number of reports evidencing various coumarins as
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The evaluation of antibacterial activities in coumarin-thaidiazole hybrids and their
metal complexes was inspired by the rising incidences of resistance of microbes to existing
antibiotics, which necessitates the design of novel therapeutic agents [30,31]. In terms of
the Cu(II) and Zn(II) complexes, the antibacterial study was driven by previously observed
effects of an increase in activities of coumarins upon their complexation with various
metal salts [16,17,32]. The assessment of anti-AChE potency in hybrids and complexes
obtained was inspired by a number of reports evidencing various coumarins as potent
AChE inhibitors [3]. The inspiration for the examination of anti-activity of Cu(II) and
Zn(II) complexes originated from the hypothetical involvement of Cu(II) and Zn(II) ions in
processes responsible for the progress of neurodegenerative disorders [33–35] and from the
hypothesis that the metal complexes may enhance the antineurodegenerative activity of
the coumarin-thiadiazole ligands [27,36,37].
2. Results and Discussion
2.1. Synthesis
The synthetic strategy was inspired by our previous attempts for the isolation of
coumarin-thiadiazole hybrids, namely the formation of resorcynyl-substituted thiadiazoles,
which enabled the possibility for subsequent application of the classical von Pechmann
conditions to form the 6-(1,3,4-thiadiazoyl)-coumarin derivatives [28]. The relatively low
yields of those products, together with their sparing solubility, significantly limited their
usefulness as potential therapeutic agents. Therefore, in this work, the synthesis focused
on the formation of suitable coumarin intermediates which in the second synthetic step
would offer the possibility for modification towards the formation of coumarin-thiadiazole
hybrids (Figure 1). According to this approach, either the Knoevenagel condensation as a
convenient source of easily modifiable coumarin-3-carboxylic acids or the von Pechmann
reaction as a source of coumarins possessing the carboxyl substituent at the aromatic ring
was considered. Finally, the choice of von Pechmann conditions to form the 7-hydroxy-4methylcoumarin-8-carboxylic acid intermediate was considered optimal, as the presence of
the 7-OH group at the coumarin ring provides the coumarin-thiadiazole hybrids with the
convenient metal-chelating pocket.
The synthetic pathway employed in this work involved four major steps. In the first
step, the mentioned von Pechmann condensation was applied for the isolation of a suitable
coumarin precursor, namely the 7-hydroxy-4-methylcoumarin-8-carboxylic acid 1 [38].
The presence of the carboxyl group at the 8 position of coumarin 1 enabled the possibility
for its subsequent transformation into a thiadiazole hybrid. Thus, in the second synthetic
step, a classical POCl3 -mediated procedure was applied for the synthesis of coumarinthiadiazole hybrids. Three various thiosemicarbazides used as substrates resulted in the
formation of the corresponding hybrids 2, 3, and 5, while the acetylation of primary amine
moiety in 2 with the use of the aqueous acetic anhydride extended the series and lead to
the formation of the amide 4. In the final synthetic step, the coumarin-thiadiazole hybrids
2–5 were used as ligands in the synthesis of Cu(II) and Zn(II) complexes (compounds 6–9,
and 10–13, respectively). The numbering system of atoms used for the discussion of results
obtained and the assignment of NMR signals is given in Figure 2.
2.2. IR(ATR) Spectroscopy
The IR-spectroscopic characteristics of the coumarin-thiadiazole hybrids consist of
several bands arising from coumarin and thiadiazole moieties (Figure 3). In all hybrids,
the most characteristic band, that of the coumarin lactone carbonyl stretch, is present at
approximately 1700–1720 cm−1 . Interestingly, an additional carbonyl stretching vibration
is observed in this region, arising most likely from keto-tautomeric forms of the hybrids.
The keto/enol-like tautomerism is a well-known feature of the thiadiazole derivatives,
and especially those substituted with phenolic rings, in which the formation of keto
tautomers manifests as the characteristic band at approximately 1730 cm−1 . Such behavior
was previously observed in resorcynyl-substituted thiadiazoles which were extensively
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2.2. IR(ATR) Spectroscopy
The IR-spectroscopic characteristics of the coumarin-thiadiazole hybrids consist of
several bands arising from coumarin and thiadiazole moieties (Figure 3). In all hybrids,
the most characteristic band, that of the coumarin lactone carbonyl stretch, is present at
approximately 1700–1720 cm−1. Interestingly, an additional carbonyl stretching vibration
is observed in this region, arising most likely from keto-tautomeric forms of the hybrids.
The keto/enol-like tautomerism is a well-known feature of the thiadiazole derivatives, and
especially those substituted with phenolic rings, in which the formation of keto tautomers
manifests as the characteristic band at approximately 1730 cm−1. Such behavior was previously observed in resorcynyl-substituted thiadiazoles which were extensively studied
by our group [39,40]. In the hybrids 2–5, the keto C=O stretching vibration occurs in the
region of 1720–1740 cm−1. In 2 and 5, it overlaps with the C=O band of the coumarin lactone
while in 3 and 4 the keto and the lactone bands are well-resolved. The proposed tautomeric forms of coumarin-thiadiazole hybrids isolated in this work are given in Figure 4.
In addition to the keto and lactone C=O bands, the spectrum of compound 4 shows the
third C=O stretching band arising from the amide moiety, which partly overlaps with the
keto C=O band and disrupts its symmetry.

Figure
Figure 3.
3. Comparison
Comparison of
of IR
IR (ATR)
(ATR) spectra
spectra of
of the
the coumarin-thiadiazole
coumarin-thiadiazole hybrids
hybrids 2–5
2–5..

Figure 4. Proposed enol (left) and keto (right) tautomeric forms of the coumarin-thiadiazole hybrids
2–5.

The high wavenumber region of the spectra is occupied by the series of relatively low
intensity and broad signals arising from the phenolic O-H and the amine N-H stretching
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enol
(left)
andand
ketoketo
(right)
tautomeric
formsforms
of the coumarin-thiadiazole
hybrids
Figure 4.
4. Proposed
Proposed
enol
(left)
(right)
tautomeric
of the coumarin-thiadiazole
2–5. 2–5.
hybrids

The high wavenumber
wavenumber region
region of
of the
the spectra
spectra is
is occupied
occupied by
by the series of relatively
relatively low
intensity
intensity and
and broad
broad signals
signals arising
arising from
from the
the phenolic
phenolic O-H
O-H and
and the
the amine
amine N-H
N-H stretching
stretching
vibrations.
of of
possible
hydrogen
bonding
or
vibrations. The
The broadening
broadeningofofthese
thesebands
bandsmay
maybebea result
a result
possible
hydrogen
bonding
the
tautomerism
mentioned.
The
fingerprint
region
of of
thethe
spectra
of of
2–5
is is
occupied
byby
a
or the
tautomerism
mentioned.
The
fingerprint
region
spectra
2–5
occupied
large
number
of
bands,
however,
only
a
few
of
them
are
relatively
easily
assignable
to
the
a large number of bands, however, only a few of them are relatively easily assignable to
particular
covalent
bonds.
The thiadiazole
C=N C=N
vibrations
are present
at approximately
the particular
covalent
bonds.
The thiadiazole
vibrations
are present
at approxi−1 and vary only slightly depending on the substituent present at the C15 carbon.
1600
cm
−1
mately 1600 cm and vary only slightly depending on the substituent present at the C15
−1
The
sharp
intense
band atband
1380at
cm
in all in
hybrids
may may
be assigned
to the
carbon.
Theand
sharp
and intense
1380present
cm−1 present
all hybrids
be assigned
to
−1 arises most likely from
amine
C-N
stretch
[41].
Another
characteristic
band
at
1237
cm
the amine C-N stretch [41]. Another characteristic band at 1237−1cm−1 arises most likely
the
phenolic
C-O stretching
vibration
[41]. The
at 1070
is associated
withwith
the
−1 is associated
from
the phenolic
C-O stretching
vibration
[41].band
The band
at cm
1070 cm
coumarin
nucleus.
Due
to
the
fact
that
it
is
present
in
all
spectra,
including
the
coumarin
the coumarin nucleus. Due to the fact that it is present in all spectra, including the coumaintermediate
1 and
its its
positioning,
does
not
change
rin intermediate
1 and
positioning,
does
not
changeupon
uponthe
theformation
formationof
of the
the metal
metal
complexes this band may be assigned to the in-plane C-H bending vibrations [41].
complexes this band may be assigned to the in-plane C-H bending vibrations [41].
Coordination of the coumarin-thiadiazole hybrids to Zn(II) and Cu(II) ions is accomCoordination of the coumarin-thiadiazole hybrids to Zn(II) and Cu(II) ions is accompanied with the disappearance of the band assigned to keto C=O stretch, suggesting that
panied with the disappearance of the band assigned to keto C=O stretch, suggesting that
only the enol tautomer is involved in the formation of complexes (Figure 5 and Supplemenonly the enol tautomer is involved in the formation of complexes (Figure 5 and Suppletary Figures S1–S3). This hypothesis is further supported by X-ray diffraction results (see
mentary Figures S1–S3). This hypothesis is further supported by X-ray diffraction results
Section 2.4). Moreover, a trend in the positioning of thiadiazole C=N vibrations maxima
(see Section 2.4). Moreover, a trend in the positioning of thiadiazole C=N vibrations max1
is observed, namely the shift towards lower wavenumbers by approximately 10 cm−−1
ima is observed, namely the shift towards lower wavenumbers by approximately 10 cm
compared to that of the corresponding free coumarin-thaidiazole ligand. Moreover, in
compared to that of the corresponding free coumarin-thaidiazole ligand. Moreover, in all
all complexes, the region of 3400–3000−1cm−1 is dominated by low intensity and broad
complexes, the region of 3400–3000 cm is dominated by low intensity and broad bands,
bands, which obscures all other bands expected to be seen in this range. Such a feature is
which obscures all other bands expected to be seen in this range. Such a feature is characcharacteristic of the presence of water, which in the complexes may act as an aqua ligand,
consistent with the microanalysis data (Section 2.5). Additionally, a series of subtle changes
related to the formation of coordination bonds are present between 550–450 cm−1 [27,29].
As expected, the complex formation either does not affect the positioning of the lactone
C=O band or only the slight shifts are observed. This gives evidence that the coumarin
lactone oxygen does not partake in binding to the metal centers. In the case of Zn(II)
complexes, the lactone band is notably broader, most likely due to the overlap with the
C=O stretching band of the acetate, except in complex 12 (Supplementary Figure S2), in
which the lactone C=O band remains unaffected.
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acteristic of higher than expected integral values are correlated with C19 and C20 carbons,
and no additional correlations were found for those signals. It is unlikely that this effect
is caused by the keto/enol tautomers, as in polar solvents such as DMSO the equilibrium
is shifted towards the enol tautomer, and signals arising from the keto tautomers are not
expected [39,40]. The isomers are more likely as a result of a free rotation around the thi7 of 23
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The formation of isomers in 5 is supported by the lack of the thiosemicarbazide signals,
Due to the paramagnetic character of Cu(II) ions [41], the NMR spectra of complexes
which otherwise would suggest the presence of unreacted substrate. Moreover, the HSQC
6–9 were not acquired. In the case of Zn(II) complexes 10–13, although the diamagnetic
experiments (not shown) confirmed that those hydrogens with NMR signals characteristic
character of Zn(II) ions made the acquisition of NMR spectra feasible [41] the sparing solof higher than expected integral values are correlated with C19 and C20 carbons, and
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ure 7. As expected, almost all signals in the spectra of Zn(II) complexes were significantly
caused by the keto/enol tautomers, as in polar solvents such as DMSO the equilibrium
broader compared to those of the corresponding free ligands. Nevertheless, the spectra of
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10–13 shown some features which were characteristic of complex formation occurring in
expected [39,40]. The isomers are more likely as a result of a free rotation around the
a similar manner to that previously reported by our group [27,29]. In more detail, all sigthiadiazole-NH-phenyl bonds, which may generate additional asymmetry and increase or
nals present in the Zn(II) complexes spectra were upfield-shifted compared to those of the
broaden the phenyl aromatic peaks.
corresponding
free ligands. Secondly,
complexation
disappearDue to the paramagnetic
character the
of Cu(II)
ions [41],was
theaccompanied
NMR spectraby
of acomplexes
ance
of
the
–OH
peak,
evidencing
this
group
as
one
of
the
metal-binding
sites
of the cou6–9 were not acquired. In the case of Zn(II) complexes 10–13, although the diamagnetic
character of Zn(II) ions made the acquisition of NMR spectra feasible [41] the sparing
solubility of complexes resulted in their relatively low-quality spectra as exemplified in
Figure 7. As expected, almost all signals in the spectra of Zn(II) complexes were significantly
broader compared to those of the corresponding free ligands. Nevertheless, the spectra
of 10–13 shown some features which were characteristic of complex formation occurring
in a similar manner to that previously reported by our group [27,29]. In more detail, all
signals present in the Zn(II) complexes spectra were upfield-shifted compared to those
of the corresponding free ligands. Secondly, the complexation was accompanied by a
disappearance of the –OH peak, evidencing this group as one of the metal-binding sites of
the coumarin-thiadiazole ligand. Moreover, in 10 and 11 (Supplementary Figure S5), an
additional singlet present at approximately 1.87 ppm pointed at the acetate ion partaking
in the coordination to Zn(II). The spectrum of complex 12 did not indicate the presence of
the acetate ion. The signal present at 1.91 ppm in the NMR spectrum of 12 was identified as
an acetic acid trace impurity [42] as its integration did not correspond with the remaining
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2.4. X-ray Crystallography
Although numerous attempts at the isolation of single crystals suitable for XRD
analysis remained unsuccessful, we were able to isolate a single crystal of Zn(II) complex
11 (Figure 8A). The crystal suitable for XRD was grown by slow cooling of a hot DMSO
solution of 11 with the addition of a minimal amount of H2 SO4 . Such conditions resulted

Int. J. Mol. Sci. 2021, 22, 9709

9 of 23

in the formation of a trinuclear Zn(II) cluster, wherein each Zn(II) ion is chelated by the
phenolic oxygen of the coumarin and the nearest N atom of the thiadiazole heterocycle,
while the second thiadiazole nitrogen donates its lone pair of electrons to another Zn(II)
It is worth emphasizing that the coordination mode of coumarin-thiadiazole hybrid
Int. J. Mol. Sci. 2021, 22, x FOR PEERion.
REVIEW
10 ofto23
the metals is consistent with the IR-spectroscopic data and supports the enol form of the
coumarin-thiadiazole ligand involvement in the metal coordination.
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2.5. Microanalysis (C, H, N, and S) and Atomic Absorption Spectroscopy (AAS)
In most cases, the microanalysis results were acceptable and demonstrated a good
match between the calculated and experimental data (Table 1). The purity of coumarinthiadiazole hybrids 2–5 was sufficient for both complexation reactions as well as for the
biological testing.
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Apparently, the trinuclear Zn(II) core is stabilized by the sulfate ion, which forms
coordination bonds with each Zn(II) ion through three oxygen atoms. Interestingly, the
central part of the Zn(II) triangle is occupied by the hydroxyl group supporting the hypothesis of neutral charge of the cluster formed. The positive charge of +6 originating
from three Zn(II) ions is in this case balanced by the deprotonated phenolic groups of three
coumarin-thaidiazole ligands, one sulfate anion, and the lone hydroxyl group mentioned.
Additionally, the crystal structure is stabilized by interactions with DMSO (solvent) and a
number of water molecules (Figure 8A,B).
The complex 11 crystallized in the P-1 space group. The three parts are related by the
quasi three fault axis going through the sulfate and hydroxide anions. The coordination
spheres of Zn(II) ions are not the same. The Zn1 and Zn2 coordination spheres are almost
an ideal bi-tetragonal pyramid while the Zn3 one is a distorted tetragonal pyramid (see
Figure 8C). Additionally, the cluster structure is stabilized by three pairs of hydrogen
bonds between neighboring coumarin-thiadiazoles molecules (see Figure 8B). The web
of intermolecular hydrogen bonds between neighboring complexes is built via carbonyl
O3B’ (– denotes other complex molecule) and O7-H, and O15-HB. The channels along
the a direction in the crystal are filled with disordered water molecules. The detailed
crystallographic data are given in Supplementary materials (Figure S7, Tables S1–S3).
2.5. Microanalysis (C, H, N, and S) and Atomic Absorption Spectroscopy (AAS)
In most cases, the microanalysis results were acceptable and demonstrated a good
match between the calculated and experimental data (Table 1). The purity of coumarinthiadiazole hybrids 2–5 was sufficient for both complexation reactions as well as for the
biological testing.
Table 1. Microanalysis (C,H,N,S), AAS, molecular weight, yields, and chemical formulae of coumarin-thiadiazole hybrids
and their Cu(II) and Zn(II) complexes 2–13.
%C

%H

%N

%S

%M (AAS)

Yield

Calc.

Found.

Calc.

Found.

Calc.

Found.

Calc.

Found.

Calc.

Found.

[%]

MW
[g/mol]

Formula

2

52.36

49.54

3.30

3.32

15.26

13.75

11.65

11.75

-

-

72

275.28

C12 H9 N3 O3 S

3

53.97

48.58

3.83

3.83

14.52

13.28

11.08

11.32

-

-

93

289.31

C13 H11 N3 O3 S

4

52.99

51.79

3.49

3.54

13.24

12.81

10.10

11.25

-

-

87

317.32

C14 H11 N3 O4 S

5

61.53

63.90

3.73

3.57

11.96

11.65

9.12

13.29

-

-

59

351.38

C18 H13 N3 O3 S

6

42.13

41.37

3.54

3.01

12.28

12.33

9.37

10.12

9.29

8.01

80

684.15

C24 H24 N6 O10 S2 Cu

7

43.85

43.45

3.96

3.46

11.80

11.70

9.00

10.27

8.92

8.95

53

712.21

C26 H24 N6 O8 S2 Cu

8

43.78

43.41

3.67

3.17

10.94

10.84

8.35

9.88

8.27

7.10

77

768.23

C28 H28 N6 O12 S2 Cu

9

51.70

49.40

3.86

3.24

10.05

10.69

7.67

12.56

7.60

6.46

68

836.35

C36 H32 N6 O10 S2 Cu

10

38.68

38.44

3.48

3.19

9.67

10.73

7.37

9.22

15.04

13.80

83

434.73

C14 H15 N3 O7 SZn

11
11 *

40.15
37.70

39.26

3.82
3.32

3.23

9.36
9.65

10.16

7.14
12.27

8.16

14.57
15.02

13.70

78

448.76
1306.28

C15 H17 N3 O7 SZn
C41 H43 N9 O18 S5 Zn3

12 **

45.82

45.78

3.30

3.27

11.45

11.35

8.74

10.24

8.91

6.94

89

734.03

C28 H24 N6 O10 S2 Zn

13
13 **

47.03
53.90

49.61

3.75
3.52

3.40

8.23
10.48

10.77

6.28
7.99

12.66

12.80
8.15

6.86

71

510.83
802.15

C20 H19 N3 O8 SZn
C36 H28 N6 O8 S2 Zn

No.

*—calculated according to the isolated crystal structure, **—calculated for 2:1 (ligand:metal) ratio × 2H2 O.

In terms of the complexes 6–13, the microanalysis data together with the AAS results
allowed for an estimation of the ligand:metal ratio. The data from Cu(II) complexes 6–9
supported the hypothesis of 2:1 (ligand:metal) ratio with additional four aqua ligands
in the coordination sphere. These results are consistent with the IR spectra (Section 2.2),
which suggest the presence of additional water molecules. Moreover, in the context
of the ligand:metal ratio, there is a similarity between Cu(II) complexes 6–9 and those
previously reported by our group [20,29], which support the hypothesis that the Cu(II)
complexes 6–9 consist of two coumarin-thiadiazole hybrid ligands bound to one central
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Cu(II) ion with the coordination bonds formed via lone pairs of electrons coming from the
deprotonated phenolic group and the nearest (in space) thiadiazole nitrogen. Additionally,
the coordination sphere is filled most likely with four water molecules, which in turn
enables the variety of coordination numbers (from 4 up to 8). The lack of clear d-d* bands
in the UV-Vis spectra of Cu(II) complexes (Section 2.6), together with their brown color,
suggests that the octahedral geometry and the coordination number of 6 is rather unlikely
as brown-colored octahedral Cu(II) complexes are scarce. In addition, the coordination
number of 7 in Cu(II) complexes is uncommon. Therefore, the most possible coordination
numbers are 4, 5, and 8. The more detailed determination of geometry in the Cu(II)
complexes 6–9 will be the subject of future studies.
The microanalysis and the AAS data of Zn(II) complexes 10–13 are more ambiguous.
Initially, the percentage C, H, N, and S were calculated according to the structural features
revealed by the NMR spectra, namely the presence/absence of the acetate ion and aqua
ligands. A relatively good match between the calculated and experimentally determined
values was achieved for complexes 10–12. In more detail, the data from 10 and 11 fit best
with a mononuclear Zn(II) complex incorporating one coumarin-thiadiazole ligand, one
acetate ion, and two water molecules. The stoichiometry of 1:1:1 (ligand:metal:acetate)
is consistent with the remaining experimental data and especially with the NMR spectra
(Section 2.3). In this context, the complexes 10 and 11 demonstrated similarity to our
previously reported Zn(II) complexes incorporating thiadiazole-derived ligands [27,29].
Recalculation according to the isolated crystal structure of 11 (Section 2.4) shows notable
discrepancies between the theoretical and physically obtained data (Table 1). It is therefore
highly likely that the non-crystalline Zn(II) complexes 10 and 11 do not occur as trinuclear
Zn(II) clusters, unlike the crystal isolated. Given the fact that the single crystal of complex
11 was isolated from a sample containing DMSO solvent and a small amount of sulfuric
acid, it is likely that the sulfate was exchanged with the acetate ion, which affected the
crystal formation. Moreover, separate trials aimed at the isolation of Zn(II) complexes
with the use of Zn(II) sulfate have remained unsuccessful or have given a highly insoluble
material. Based on these experiments, the structures of Zn(II) complexes are proposed as
mononuclear with 1:1:1 (ligand:metal:acetate) stoichiometry.
The chelating of the Zn(II) ion by coumarin-thiadiazole hybrids is most likely similar
to that of the Cu(II) complexes 6–9 and occurs via the phenolic oxygen and one of the
thiadiazole nitrogens. Moreover, the known crystal structure of Zn(II) acetate used for
the isolation of complexes supports the bidentate binding mode of the acetate ion and
the presence of two aqua ligands [43]. This, in turn, authenticates the hypothesis of
distorted octahedral structures of complexes 10, 11, and 13. The microanalysis and AAS
data for complex 12 is consistent with the NMR data suggesting the lack of an acetate ion.
In this case, the complex very likely consists of two coumarin-thiadiazole ligands, and the
coordination sphere is completed with two aqua ligands, hence the octahedral geometry of
the complex. The elemental analyses of 13 did not give clear information regarding the
stoichiometry of the complex. Moreover, the presence of the acetate ion has not been fully
confirmed. It is therefore highly likely that complex 13 has not been isolated in pure form
or multiple structures and geometries are involved.
2.6. UV-Vis Spectroscopy
All UV-Vis spectra were recorded in 0.2 mM solutions in methanol (Figure 9A).
Regardless of the overall sparing solubility of all compounds, the solubility of coumarinthiadiazole hybrids 2–5 was slightly higher compared to their corresponding metal complexes 6–13. In the coumarin-thiadiazole hybrids 2–5, the electronic absorption gives rise
to the π → π* transitions. The positioning of λmax in compounds 2–5 differs most likely
depending on the substituents present at the thiadiazole moiety but lays within the range
characteristic of both thiadiazoles and coumarins. In more detail, the spectra of all compounds are dominated by one broad band with the λmax within the range of 240–360 nm
and the broadening towards the lower energy region. In addition, the broadening of the
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main absorption band may be a result of the molecular aggregation processes. This effect
manifests particularly strongly in compound 4, most likely a result of head-to-tail aggregation type [44]. The substituents, such as the phenolic –OH or primary and secondary amine
moieties attached to the carbon C15, may be a source of n → π* transitions, but those are
Int. J. Mol. Sci. 2021, 22, x FOR PEERmost
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likely overlapped with the main π → π* band and hence are not observed. Moreover,
the interplay between keto- and enol-like tautomers may also affect the energy of electronic transitions and contribute to the broadening of the main absorption band in hybrids
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(ESIPT) processes [45]. Moreover, the molecular aggregation evidenced by the UV-Vis
spectroscopy (Section 2.6) may contribute to the emission characteristics via aggregationinduced emission (AIE) [52,53], and enhance the possible ESIPT-related effects in coumarin-thiadiazole hybrids 2–5. In order to verify the ESIPT hypothesis, an additional set of
studies such as the time-resolved emission measurements will be performed in the future.
Undoubtedly, both emission bands in the coumarin-thiadiazole hybrids 2–5 depend
on the substituent present at carbon C15, which primarily affects the intensity of the high
energy emission band, while its influence on the lower energy emission bands is more
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2.7. Fluorescence Spectroscopy
The steady-state fluorescence spectra were recorded in methanol. The samples were
prepared in the same manner as for the UV-Vis measurements. Moreover, in order to
eliminate the re-absorption processes, the samples were additionally diluted to a concentration of 0.1 mM. All spectra were recorded at identical conditions using the excitation
wavelength λex = 320 nm (Figure 9B).
The fluorescence spectra of all compounds revealed two well-resolved emission bands
referred to as the dual fluorescence phenomenon [46–48]. The high energy maximum
is observed at 380 nm. Its positioning remains practically unchanged in all compounds
but significantly varies in intensity. The positioning of the lower energy emission band
varies from 480 to 510 nm, while its intensity changes are less significant within the
series. The wavelength of high energy emission corresponds well with the enol-tautomeric
form of the 1,3,4-thiadiazole derivatives [39,40]. The lower energy band is similar to that
of the various substituted coumarins and conjugates [49–51] but may also be assigned
to the excited keto form of the hybrid resulting from the excited-state proton transfer
(ESIPT) processes [45]. Moreover, the molecular aggregation evidenced by the UV-Vis
spectroscopy (Section 2.6) may contribute to the emission characteristics via aggregationinduced emission (AIE) [52,53], and enhance the possible ESIPT-related effects in coumarinthiadiazole hybrids 2–5. In order to verify the ESIPT hypothesis, an additional set of studies
such as the time-resolved emission measurements will be performed in the future.
Undoubtedly, both emission bands in the coumarin-thiadiazole hybrids 2–5 depend
on the substituent present at carbon C15, which primarily affects the intensity of the
high energy emission band, while its influence on the lower energy emission bands is
more subtle. The highest intensity of the 380 nm band is characteristic of the aminosubstituted hybrid 2 and its corresponding complexes 6 and 10. In phenylamino-substituted
compounds 5, 9, and 13, this band is moderately intense, while in the remaining compounds
it is least intense. The extent to which the substituent at C15 affects the intensities of the
emission bands allows the assignment of 380 nm maximum to the thiadiazole moiety,
whereas the 480–510 nm is more characteristic of the emission from the coumarin nucleus.
In the complexes 6–13, in addition to the C15 substituent, the intensities of both
emission bands are affected by the presence of the central metal. In more detail, the ratio
between intensities of both emission bands changes upon the complexation with metal salts.
Compared to the free ligands 2–5, all complexes demonstrate a decrease in intensity of their
380 nm band, which in some cases is accompanied by a slight increase in the intensity of
the lower energy emission. The decrease in intensity of the fluorescence emission in Cu(II)
and Zn(II) complexes is consistent with the internal conversion-based dissipation of the
excitation energy [27,29]. Secondly, a slight increase in the lower energy emission band is
characteristic of the aggregation-induced emission processes (AIE) [52,53]. Therefore, the
internal conversion together with the AIE phenomenon is considered responsible for the
fluorescence emission characteristics in the complexes 6–13.
Slight differences in the positioning of the emission bands give evidence that the
complexation of coumarin-thiadiazole hybrids 2–5 is accompanied by only a minor geometry change of their fluorophore systems. It is highly likely that both the free coumarinthiadiazole ligands and their corresponding metal complexes are relatively planar and
rigid. Both the relative planarity and rigidity in the free ligands 2–5 result from two factors,
namely the intramolecular hydrogen bonding between the phenolic OH- group and nearby
thiadiazole nitrogen, and the possibility for keto/enol-like tautomerism (Figure 4). In the
complexes 6–13, both the intramolecular hydrogen bonding and the keto/enol tautomerism
are suppressed by the presence of the central metal but as it is seen in the crystal structure (Figure 8) the relative planarity and rigidity of the coumarin-thiadiazole ligand is
maintained by the coordination bonds formed.
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2.8. Antibacterial Activity
The antibacterial activity of all compounds was evaluated by determining their minimum inhibitory concentrations (MIC) (Table 2). Compared to those of the commercially
available antibiotics, all compounds demonstrated rather poor activities against the species
tested, except the activities against P. aeruginosa which were similar or higher than those
of kanamycin and gentamicin. Whilst these antibiotics, however, are not commonly
used in the treatment of P. aeruginosa infections, the beta-lactam antibiotics (penicillins
or cephalosporins) are the first choice drugs for the treatment of P. aeruginosa infections.
What is interesting is that in most cases the coumarin-thiadiazole hybrids were more active
than their corresponding complexes. The highest activity against P. aeruginosa was observed
in the amino-substituted hybrid 2, while the phenylamino-substituted hybrid 5 together
with both Zn(II) complexes 10 and 13 demonstrated the second highest activity against
this strain. The activities against the remaining species, namely the E. coli and S. aureus,
were notably lower. Moreover, the hybrids 2 and 5 and complex 13 showed some activity
against S. aureus but their MIC values were notably higher compared to those of all three
controls used.
Table 2. Minimal inhibitory concentration (MIC) and minimal bactericidal concentration (MBC) values determined for
coumarin-thiadiazole hybrids and their corresponding Cu(II) and Zn(II) complexes 2–13.
MIC/MBC a [mg/mL]
Gram-Negative

Compound.

Gram-Positive

E. coli

P. aeruginosa

S. aureus

S. epidermidis
ATCC12228

S. epidermidis
ATCC 35984

2

1.04

1.04

0.13/2.1

0.26

0.13/2.1

3

3.12

3.12

3.12

1.56

3.12

4

1.56

3.12

0.78

1.56

1.56

5

0.78

1.56

0.19/1.56

0.39

0.39/1.56

6

4.2

4.2

4.2

2.1

4.2

7

4.2

4.2

4.2

4.2

4.2

8

5.0

5.0

>5.0

5.0

2.5

9

3.12

>3.12

>3.12

0.78

0.39

10

3.12

1.56

3.12

1.56

3.12

11

>5.0

5.0

5.0

5.0

>5.0

12

3.12

6.25

3.12

3.12

1.56

13

1.56

1.56

0.39

0.78

0.78

chloramphenicol

3.9 × 10−3

0.25

7.8 × 10−3

7.8 × 10−3

1.56 × 10−2

gentamicin

1.9 × 10−3

1.9

0.97 × 10−3

0.24 × 10−3

3.12 × 10−2

kanamycin

7.8 × 10−3

NI

3.9 × 10−3

1.9 × 10−3

NI

a —determined

only in the tested range of concentrations, which differed for individual compounds (0.13–4.2 mg/mL in compounds: 2, 6,
7; 0.16–5 mg/mL in compounds 8 and 11; 0.19–6.25 mg/mL in compounds: 3, 4, 5, 9, 10, 12, 13).

Generally, compared to Gram-negative species the Gram-positive bacteria were less
resistant to exposure to all compounds tested. In more detail, the amino- and phenylaminosubstituted hybrids (2 and 5, respectively) demonstrated moderate activity against S. epidermidis.
Interestingly the activities of the corresponding metal complexes were comparable only
in the case of hybrid 5, while the remaining complexes showed a notably lower activity
against the Gram-positive species tested. The relatively high MIC values of all compounds
tested was the reason why the minimal bactericidal concentrations (MBC) were determined
only for the most active compounds 2 and 5 and only against two bacterial strains (S. aureus
and S. epidermidis ATCC 35984) (Table 2).
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2.9. AChE Inhibition Activity
In order to determine the time span of experiments required for the reliable determination of IC50 values, the absorption intensity changes at 412 nm in Tacrine (reference
compound) were monitored for 30 min at 37 ◦ C with 1-min intervals. The notable changes
were observed during the first 5 min, while after that time the slope angle remained practically unchanged. The IC50 values of compounds 2–13 were determined based on the data
recorded after 5 min of the reaction. In the blank experiment (without inhibitor added), the
absorption intensity increase during 30 min was linear (R2 = 0.999).
The results obtained (Table 3) show only a moderate anti-AChE activity of compounds 2–13 compared to that of the Tacrine control. In addition, no obvious trends in the
structure–activity relationship were observed and no significant differences were noted
between activities of the coumarin-thiadiazole hybrids and their corresponding complexes.
Nonetheless, it is noteworthy that the three most active molecules, namely the ligand 4
and its corresponding Cu(II) and Zn(II) complexes (8 and 12, respectively), have an amide
moiety, consistent with a number of reports evidencing the importance of this group in
the AChE inhibition ability of coumarins [54–56]. It is also worth noticing that in terms of
the structure–activity relationship, the complexes 8 and 12 incorporate the ligand which
tends to form complexes with a 1:1 ligand:metal ratio, regardless of the identity of the
central metal.
Table 3. Anti-AChE activity of coumarin-thiadiazole hybrids and their corresponding Cu(II) and
Zn(II) complexes 2–13.
Compound

IC50 [µM] ± SD [µM]

2

0.218 ± 0.0084

3

0.211 ± 0.0123

4

0.181 ± 0.0123

5

0.299 ± 0.0194

6

0.232 ± 0.0119

7

0.198 ± 0.0061

8

0.174 ± 0.0181

9

0.190 ± 0.0038

10

0.228 ± 0.0083

11

0.234 ± 0.0185

12

0.184 ± 0.0069

13

0.187 ± 0.0080

Tacrine

0.053 ± 0.0036

In spite of the fact that all compounds demonstrated about 4-fold weaker activities
compared to that of the reference compound, their activities were still comparable with
those of several other coumarin and thiadiazole derivatives [14,57,58]. On the other hand,
a number of reports deal with notably more active coumarin hybrids derived from the
commercial AChE inhibitors such as Tacrine or Donepezil [59–61]. It should also be noted
that there is a significant decrease in the solubility of the complexes in relation to their
free ligands, which likely compromise the applicability of 2–13 in aqueous environments,
which mimic physiological conditions.
3. Experimental
3.1. Materials and Methods
All chemicals used for the syntheses were of reagent grade or higher. 2,6-dihydroxybenzoic
acid, thiosemicarbazides, acetic anhydride, phosphorous oxychloride, and DMSO-d6 were
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purchased from Aldrich (Darmstadt, Germany). Concentrated HCl, solid NaOH, were
purchased from ChemPur (Poland). Ethanol, methanol, and metal salts were purchased
from Avantor (Gliwice, Poland). All solvents were of 99% purity (HPLC grade) or higher.
The NMR spectra were acquired in d6 -DMSO on a Bruker Avance III spectrometer
(500 MHz). The infrared spectra were recorded on a Shimadzu IRSpirit FT-IR apparatus equipped with the QATR-S ATR adapter. The UV-Vis and steady-state fluorescence
spectra were recorded on a Tecan Infinite 200 microplate reader (Tecan Austria GmbH,
Grödig/Salzburg, Austria) using 96-well plates. Melting point values were recorded
on the Stuart SMP20 apparatus within the range of 25–300 ◦ C and were uncorrected.
The Cu(II) and Zn(II) content in the complexes was determined using the PerkinElmer
AAS 370 apparatus.
Collection of the X-ray diffraction data was accomplished at 293 K using a SuperNova
diffractometer with CuKα radiation and a CCD detector (ATLAS S2). Cell refinement and
data collection as well as data reduction and analysis were performed with CRYSALISPRO
software [62]. Due to crystal instability, the data collection time was reduced which
influenced the final goodness of data. The data reduction was performed using the twins
option in the software due to a relatively low crystal quality. The final structure was
solved using direct methods implemented in SHELXT [63] software and refined using
SHELXL [64] in the P-1 group after omitting the number of wrong reflections which in
automatic mode led to the P1 symmetry. The C–H and O–H hydrogen atoms were located
in idealized average geometrical positions. Scattering factors were taken from Tables 6.1.1.6
and 4.2.4.2 in [65].
The antibacterial properties were determined against Gram-positive (Staphylococcus aureus ATCC 6538 and Staphylococcus epidermidis ATCC 35984), and Gram-negative (Escherichia
coli ATCC 10536 and Pseudomonas aeruginosa ATCC 15442) bacterial strains, obtained from
the Department of Biotechnology and Bioinformatics, Faculty of Chemistry, Rzeszow University of Technology. Gram-positive Staphylococcus epidermidis ATCC 12228 was kindly
provided from the Chair and Department of Medical Microbiology Medical University
of Lublin. All chemicals used for antibacterial analysis were of reagent grade or higher.
Dimethyl sulfoxide (99%) was purchased from Aldrich (Darmstadt, Germany), as well as
Mueller Hinton Broth (MHB) and Mueller Hinton Agar (MHA). The commercially available antibiotics chloramphenicol and kanamycin (Carl ROTH, Karlsruhe, Germany), and
gentamicin (Aldrich, Darmstadt, Germany) were used as reference standards. All reagents
and bacterial cultures were prepared using a Laminar Flow Cabinet ESCO Airstream.
The AChE inhibition assay was performed on 96-well plates using a Tecan Infinite 200
microplate reader (Tecan Austria GmbH, Grödig/Salzburg, Austria). Acetylcholinesterase
(E.C. 3.1.1.7) from Electrophorus electricus, acetylthiocholine iodide (substrate), Tacrine hydrochloride hydrate, and Ellman’s reagent were purchased from Sigma-Aldrich (St. Louis,
MO, USA).
3.2. Synthesis of 7-Hydroxy-4-methyloumarin-8-carboxylic Acid (1)
This compound was obtained according to a previously published procedure [38] with
only minor modifications. The mixture of 2,6-dihydroxybenzoic acid (5.00g, 32.00 mmol)
and ethyl acetoacetate (4.22g, 32.00 mmol) was stirred on an ice bath and 15 mL of
cold, concentrated H2 SO4 (15 mL) was added slowly. After 15 min of stirring, the
ice bath was removed and the stirring was continued at ambient temperature for another 12 h. The mixture was then poured onto ethanol (25 mL) with ice (100 g) and
the resulting solid was filtered off, washed with water, and allowed to dry on air yielding 5.71g of 1. Yield: 5.71 g (80%); C11 H8 O5 (220.18 g/mol); M.P.: 266–268 ◦ C; 1 H-NMR
(DMSO): δ = 11.16 ppm (s, 2H, H7, (–OH), H12, (–COOH)), 7.67 (d, 1H, H5, J = 8.8 Hz),
6.91 (d, 1H, H6, J = 8.8 Hz), 6.19 (d, 1H, H3, J = 1.1Hz), 2.38 (d, 3H, (–CH3 ), J = 1.1Hz); IR
(ATR): 3358, 2858, 2653, 1681, 1643, 1595, 1561, 1385, 1223, 1117, 1068, 1034, 826, 651, 607,
550 cm−1 ;
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3.3. Synthesis of Coumarin-Thiadiazole Hybrids (2, 3, and 5)
The compound 1 (3.0 g, 13.6 mmol) was suspended in POCl3 (12 mL) and stirred at
room temperature for 20 min. An equivalent of appropriate thiosemicarbazide was then
added and the reaction mixture was refluxed at 75 ◦ C and stirred for 6 h. The mixture was
then cooled down to 30 ◦ C and the excess POCl3 was quenched by slow addition of small
aliquots of water. The mixture was then refluxed at 105 ◦ C for 12 h, cooled down, and the
pH was brought to approximately 7.5 with a saturated solution of NaOH. The precipitate
formed was filtered off, dried, and recrystallized from methanol.
(2) Yield: 2.69 g (72%); C12 H9 N3 O3 S (275.28 g/mol); calc: C 52.36, H 3.30, N 15.26,
S 11.65%, found: C 49.54, H 3.32, N 13.75, S 11.75%; M.P.: >300 ◦ C; 1 H-NMR (DMSO):
δ = 13.24 ppm (s, 1H, H7, (–OH)), 7.75 (d, 1H, H5, J = 8.9 Hz), 7.68 (s, 2H, H17, (–NH2 )),
7.05 (d, 1H, H6, J = 8.9Hz), 6.28 (s, 1H, H3 (vinyl)), 2.44 (s, 3H, H11 (–CH3 )); IR (ATR):
3385, 3300, 3116, 1735, 1698, 1600,1518, 1382, 1302, 1237, 1185, 1069, 1014, 881, 815, 719,
597, 447 cm−1 ; UV-Vis (MeOH): λmax = 316 nm; fluorescence (MeOH): λEm1(Ex320) = 380 nm,
λEm2(Ex320) = 480 nm.
(3) Yield: 2.91 g (93%); C13 H11 N3 O3 S (289.31 g/mol); calc: C 53.97, H 3.83, N 14.52,
S 11.08%, found: C 48.58, H 3.83, N 13.28, S 11.32%; M.P.: 264–266 ◦ C; 1 H-NMR (DMSO):
δ = 13.23 ppm (s, 1H, H7, (–OH)), 8.12 (d, 1H, H17(–NH–), J = 4.8 Hz), 7.76 (d, 1H, H5,
J = 8.8 Hz), 7.05 (d, 1H, H6, J = 8.9Hz), 6.29 (s, 1H, H3 (vinyl)), 2.98 (d, 3H, H18 (–CH3 ),
J = 4.8 Hz), 2.44 (s, 3H, H11 (–CH3 )); IR (ATR):3332, 3273, 3002, 1742, 1717, 1599, 1559, 1498,
1380, 1304, 1237, 1165, 1070, 878, 842, 810, 748, 538 cm−1 ; UV-Vis (MeOH): λmax = 318 nm;
fluorescence (MeOH): λEm1(Ex320) = 381 nm, λEm2(Ex320) = 495 nm.
(5) Yield: 2.84 g (59%); C18 H13 N3 O3 S (351.38 g/mol); calc: C 61.53, H 3.73, N 11.96,
S 9.12%, found: C 63.90, H 3.57, N 11.65, S 13.29%; M.P.: 294–297 ◦ C; 1 H-NMR (DMSO):
δ = 13.06 ppm (s, 1H, H7, (–OH)), 10.74 (s, 1H, H17(–NH–)), 7.79 (d, 1H, H5, J = 8.9 Hz),
7.69 (d, 2H, H19, J = 8.3Hz), 7.39 (t, 2H, H20, J = 7.9Hz), 7.06 (m, 2H, H6, H19), 6.29
(s, 1H, H3 (vinyl)), 2.44 (s, 3H, H11 (–CH3 )); IR (ATR):3202, 2949, 1721, 1700, 1593, 1497,
1452, 1380, 1299, 1236, 1172, 1070, 895, 748, 692, 498 cm−1 ; UV-Vis (MeOH): λmax = 330 nm;
fluorescence (MeOH): λEm1(Ex320) = 387 nm, λEm2(Ex320) = 493 nm.
3.4. Synthesis of Coumarin-Thiadiazole Hybrid (4)
Compound 2 (2g, mmol) was refluxed in the mixture of acetic anhydride (30 mL) and
water (15 mL) for 6 h. The reaction mixture was then cooled down to ambient temperature
and the solid was filtered off, washed with water, and dried. The product was recrystallized
from methanol.
Yield: 2.01 g (87%); C14 H11 N3 O4 S (317.32 g/mol); calc: C 52.99, H 3.49, N 13.24,
S 10.10%, found: C 51.79, H 3.54, N 12.81, S 11.25%; M.P.: 298–300 ◦ C; 1 H-NMR (DMSO):
δ = 13.01 ppm (s, 1H, H7, (–OH)), 12.78 (s, 1H, H17(–NH–)), 7.82 (d, 1H, H5, J = 8.9 Hz),
7.10 (d, 1H, H6, J = 8.9Hz), 6.32 (s, 1H, H3 (vinyl)), 2.45 (s, 3H, H11 (–CH3 )), 2.26 (s, 3H,
H19 (–CH3 )); IR (ATR): 3160, 2918, 2785, 1741, 1701, 1636, 1597, 1559, 1497, 1382, 1320, 1301,
1237, 1165, 1068, 879, 773, 672, 612, 450 cm−1 ; UV-Vis (MeOH): λmax = 297 nm; fluorescence
(MeOH): λEm1(Ex320) = 380 nm, λEm2(Ex320) = 483 nm.
3.5. Synthesis of Cu(II) (6–9) and Zn(II) (10–13) Complexes
The Cu(II) and Zn(II) complexes were synthesized according to the previously reported procedures [27,29]. In the case of the Cu(II) complexes 6–9, the free ligand (2.0 mmol)
and the Cu(II) acetate monohydrate (1.0 mmol) were placed in a round bottom flask and
30 mL ethanol and water (2:1 v/v) was added. The mixture was refluxed for 6 h and cooled
down to the ambient temperature and the solid formed was collected with a centrifuge.
The crude product was then rinsed with water, dried, and recrystallized from absolute
ethanol. The Zn(II) complexes 10–13 were obtained in a similar manner, except that the
equimolar ratio of ligand and the Zn(II) acetate monohydrate was used.
(6) Yield: 0.49 g (80%); C24 H24 N6 O10 S2 Cu (684.15 g/mol); calc: C 42.13, H 3.54, N 12.28,
S 9.37, Cu 9.29%, found: C 41.37, H 3.01, N 12.33, S 10.12, Cu 8.01; M.P.: >300 ◦ C; IR (ATR):
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3379, 3298, 3110, 1731, 1583, 1519, 1497, 1389, 1234, 1164, 1068, 880,0 816, 448 cm−1 ; UV-Vis
(MeOH): λmax = 300 nm; fluorescence (MeOH): λEm1(Ex320) = 380 nm, λEm2(Ex320) = 475 nm.
(7) Yield: 0.32 g (53%); C26 H24 N6 O8 S2 Cu (712.21 g/mol); calc: C 43.85, H 3.96, N 11.80,
S 9.00, Cu 8.92%, found: C 43.45, H 3.46, N 11.70, S 10.27, Cu 8.95; M.P.: >300 ◦ C; IR
(ATR): 3385, 2997, 1715, 1582, 1389, 1303, 1233, 1163, 1070, 1047, 1014, 884, 810, 541,
453 cm−1 ; UV-Vis (MeOH): λmax = 322 nm; fluorescence (MeOH): λEm1(Ex320) = 383 nm,
λEm2(Ex320) = 487 nm.
(8) Yield: 0.47 g (77%); C28 H28 N6 O12 S2 Cu (768.23g/mol); calc: C 43.78, H 3.67, N 10.94,
S 8.35, Cu 8.27%, found: C 43.41, H 3.17, N 10.84, S 9.88, Cu 7.10; M.P.: >300 ◦ C; IR (ATR):
3440, 3164, 2921, 1730, 1700, 1582, 1521, 1496, 1440, 1386, 1315, 1302, 1164, 1068, 1013,
880, 822, 773, 672, 578, 450 cm−1 ; UV-Vis (MeOH): λmax = 299 nm; fluorescence (MeOH):
λEm1(Ex320) = 381 nm, λEm2(Ex320) = 495 nm.
(9) Yield: 0.41 g (68%); C36 H32 N6 O10 S2 Cu (836.35 g/mol); calc: C 51.70, H 3.86, N 10.05,
S 7.67, Cu 7.60%, found: C 49.40, H 3.24, N 10.69, S 12.56, Cu 6.46; M.P.: >300 ◦ C; IR (ATR):
3282, 3047, 1712, 1578, 1527, 1498, 1446, 1398, 1318, 1320, 1162, 1071, 896, 824, 748, 691,
491, 457 cm−1 ; UV-Vis (MeOH): λmax = 335 nm; fluorescence (MeOH): λEm1(Ex320) = 386 nm,
λEm2(Ex320) = 498 nm.
(10) Yield: 0.66 g (83%); C14 H15 N3 O7 SZn (434.73 g/mol); calc: C 38.68, H 3.48, N 9.67,
S 7.37, Zn 15.04%, found: C 38.44, H 3.19, N 10.73, S 9.22, Zn 13.70; M.P.: >300 ◦ C;
1 H-NMR (DMSO): δ = 7.66 (d, 1H, H5, J = 9.14 Hz), 7.51 (s, 2H, (–NH )), 6.69 (d, 1H, H6,
2
J = 9.14 Hz), 5.98 (s, 1H, H3 (vinyl)), 3.29 (s, 2H, (H2 O)), 2.38 (s, 3H, H11 (–CH3 )), 1.87 (s,
3H, (acetate –CH3 ); IR (ATR): 3294, 1716, 1581, 1518, 1497, 1394, 1229, 1165, 1068, 823, 600,
450 cm−1 ; UV-Vis (MeOH): λmax = 314 nm; fluorescence (MeOH): λEm1(Ex320) = 381 nm,
λEm2(Ex320) = 481 nm.
(11) Yield: 0.61 g (78%); C15 H17 N3 O7 SZn (448.76 g/mol); calc: C 40.15, H 3.82, N 9.36,
S 7.14, Zn 14.57%, found: C 39.26, H 3.23, N 10.16, S 8.16, Zn 13.70; M.P.: >300 ◦ C; 1 H-NMR
(DMSO): δ = 7.91 (s, 1H, H17 (–NH–)), 7.52 (s, 1H, H5), 6.68 (s, 1H, H6), 5.98 (s, 1H, H3
(vinyl)), 2.89 (s, 3H, H18 (–CH3 )); 2.38 (s, 3H, H11 (–CH3 )), 1.86 (s, 3H, (acetate –CH3 );
IR (ATR):3220, 2922, 1717, 1575, 1387, 1307, 1228, 1163, 1704, 1047, 884, 821, 599, 502,
448 cm−1 ; UV-Vis (MeOH): λmax = 316 nm; fluorescence (MeOH): λEm1(Ex320) = 380 nm,
λEm2(Ex320) = 490 nm.
(12) Yield: 0.52 g (89%);%); C28 H24 N6 O10 S2 Zn (734.03 g/mol); calc: C 45.82, H 3.30,
N 11.45, S 8.74, Zn 8.91%, found: C 45.78, H 3.27, N 11.35, S 10.24, Zn 6.94; M.P.: >300 ◦ C;
1 H-NMR (DMSO): δ = 13.01 (s, 1H, H17(–NH–)), 7.81 (s, 1H, H5), 7.09 (s, 1H, H6), 6.29 (s,
1H, H3 (vinyl)), 3.29 (s,2H, (H2 O)), 2.44 (s, 3H, H11 (–CH3 )) 2.25 (s, 3H, H19 (–CH3 )); IR
(ATR): 3430, 3158, 2922, 2783, 1739, 1700, 1584, 1498, 1441, 1383, 1320, 1302, 1236, 1165, 1068,
1013, 880, 822, 773, 672, 599, 578, 450 cm−1 ; UV-Vis (MeOH): λmax = 304 nm; fluorescence
(MeOH): λEm1(Ex320) = 379 nm, λEm2(Ex320) = 497 nm.
(13) Yield: 0,51 g (71%); C20 H19 N3 O8 SZn (510.83 g/mol); calc: C 47.03, H 3.75, N 8.23,
S 6.28, Zn 12.80%, found: C 49.61, H 3.40, N 10.77, S 12.80, Zn 6.86; M.P.: >300 ◦ C; IR
(ATR): 3275, 3064, 1717, 1584, 1498, 1452, 1387, 1301, 1229, 1163, 1072, 817, 750, 692, 499,
453 cm−1 ; UV-Vis (MeOH): λmax = 333 nm; fluorescence (MeOH): λEm1(Ex320) = 385 nm,
λEm2(Ex320) = 498 nm.
3.6. Determination of Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal
Concentration (MBC)
The antibacterial activity of all compounds was evaluated by the determination of
their minimum inhibitory concentration (MIC, mg/mL) with the use of the microdilution
method [66,67] with minor modifications. Each bacterial strain was incubated at 37 ◦ C in a
New Brunswick Innova 40 Shaker (Eppendorf AG, Hamburg, Germany) until turbidity
of 0.5 McFarland’s standard (108 CFU/mL, colony-forming units per mL) was obtained
and bacterial cultures were diluted to a final density of 105 CFU/mL. The appropriate
controls were applied in all experiments, namely a positive control of culture growth
(MHB medium with no extract added), a negative control (MHB medium with tested
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compounds and no bacterial cultures added), and solvent control (serial dilutions of
DMSO). The highest concentration of DMSO which did not affect the bacterial growth was
determined as 12.5%, and hence the DMSO content in the samples tested did not exceed
this value. The experiments were carried out in three independent repetitions (biological
replicates) within the concentration range of 0.13–6.25 mg/mL. All compounds were tested
at concentrations not compromised by insolubility. The antibiotics (chloramphenicol,
gentamicin, and kanamycin) concentration ranged from 0.03 to 500 µg/mL). The lowest
concentration of compounds tested which completely inhibited the visible growth of each
microorganism was defined as their MIC. The results were confirmed by measurement
of the optical density at 630 nm using a BIO-RAD microplate reader. The minimum
bactericidal concentration (MBC) was determined by transferring 20 µL aliquots from
wells obtained from the MIC experiment (MIC value) and two wells above the MIC value.
Aliquots were seeded on MHA plates and incubated for 24 h at 37 ◦ C. The number of
visible colonies was counted and the concentration of sample that produced <10 colonies
was considered as the MBC value. Each experiment was carried out in three independent
repetitions (biological replicates).
3.7. Determination of AChE Inhibition Activity
The acetylcholinesterase (AChE) inhibition activity of compounds 2–13 was evaluated
with the use of Ellman’s method [68] with minor modifications. Typically, 1 mg sample
of the tested compound was dissolved in 1 mL DMSO and then diluted with pH 8 buffer
solution. To the following wells of a transparent 96-well plate, increasing concentrations of
tested hybrids were applied followed by the enzyme (0.05 U/mL) and Ellman’s reagent
(1 mM). Prior to the substrate addition (1.875 mM), the plate was incubated for 10 min at
37 ◦ C. The plate was shaken for 10 s and the absorbance was then measured at 412 nm for
30 min. Tacrine was used as a standard control. The final concentration of DMSO did not
exceed 0.005% per well and was considered negligible. IC50 values were calculated as the
concentration of compound that inhibits enzyme activity by 50%. The experiments were
carried out in triplicate. The results obtained were averaged and the standard deviation
(SD) values were calculated (Supplementary Figure S8). All compounds were tested at
concentrations not compromised by insolubility.
4. Conclusions
In a conclusion, a series of novel coumarin-based hybrids and their corresponding
Cu(II) and Zn complexes were synthesized and their structural features were characterized
in detail with the use of spectroscopic techniques. The structures of Cu(II) complexes
were established as mononuclear species incorporating two coumarin-thiadiazole ligands
bound to the Cu(II) center via bidentate mode. The coordination spheres in Cu(II) complexes are occupied by four additional aqua ligands. Most of the Zn(II) complexes are
mononuclear but their hybrid ligand-to-metal ratios are 1:1 with the coordination sphere
filled with an acetate ion and two additional water molecules. The Zn(II) complexes with
coumarin-thiadiazole hybrids may form a polynuclear cluster similar to that of the crystal
structure isolated.
Taking into account the significant solubility decrease observed upon the complexation of hybrids with the metal salts, the relatively higher activities of coumarin-thiadiazole
hybrids compared to their corresponding complexes is not surprising. The sparing solubility of complexes incorporating the coumarin-derived ligands is often an issue that notably
affects their applicability as antimicrobial agents and in the case of compounds reported
herein, there is no exception. The MIC values are 100–1000 times higher than those of the
currently applied antibiotics which limits their usefulness as potential antibiotic candidates.
The Ache inhibitory action demonstrated by compounds 2–13 is more promising.
Regardless of the moderate AChE inhibition activity of all compounds, the assay identified
the amide-bearing derivatives 4, 8, and 12 as the most active within the series. This in turn
sets the direction for potential future modifications of the coumarin-thiadiazole hybrids

Int. J. Mol. Sci. 2021, 22, 9709

20 of 23

towards their amide derivatives which may demonstrate higher antineurodegenerative
potency. Given that the AChE inhibition ability is only one out of many aspects associated
with the antineurodegenerative activity, future prospects should aim at a more detailed
evaluation of the antineurodegenerative potency of compounds 2–13 involving an examination of Butyrylcholinesterase inhibition (BuChE) and amyloid fibrils suppression ability
of these compounds.
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